References
- Ahsan, W. (2019). The journey of thiazolidinediones as modulators of PPARs for the management of diabetes: A current perspective. Current Pharmaceutical Design, 25(23), 2540–2554. https://doi.org/https://doi.org/10.2174/1381612825666190716094852
- Aires, V., Brassart, B., Carlier, A., Scagliarini, A., Mandard, S. E., Limagne, E., Solary, E., Martiny, L., Tarpin, M., & Delmas, D. (2014). A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis. Molecular Nutrition & Food Research, 58(9), 1785–1794. https://doi.org/https://doi.org/10.1002/mnfr.201300962
- Badawy, A. M., El-Naga, R. N., Gad, A. M., Tadros, M. G., & Fawzy, H. M. (2019). Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway. Chemico-Biological Interactions, 308, 137–146. https://doi.org/https://doi.org/10.1016/j.cbi.2019.05.029
- Badry, D. B., Maxim, T., Ruben, A., & Charle, L. B. (2003). Comparative study of several algorithms for flexible ligand docking. Journal of Computer-Aided Molecular Design, 17, 755–763. https://doi.org/https://doi.org/10.1023/b:jcam.0000017496.76572.6f
- Banks, J. L., Beard, H. S., Cao, Y., Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., Felts, Halgren, T. A., Mainz, D. T., Maple, J. R., Murphy, R., Philipp, D. M., Repasky, M. P., Zhang, L. Y., Berne, B. J., Friesner, R. A., Gallicchio, E., & Levy, R. M. (2005). Integrated modeling program, applied chemical theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780. https://doi.org/https://doi.org/10.1002/jcc.20292
- Beekmann, K., Rubió, L., de Haan, L. H. J., Actis-Goretta, L., van der Burg, B., van Bladeren, P. J., & Rietjens, I. M. C. M. (2015). The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ). Food & Function, 6(4), 1098–1107. https://doi.org/https://doi.org/10.1039/c5fo00076a
- Calleri, E., Pochetti, G., Dossou, K., Laghezza, A., Montanari, R., Capelli, D., Prada, E., Loiodice, F., Massolini, G., Bernier, M., & Moaddel, R. (2014). Resveratrol and its metabolites bind to PPARs. Chembiochem: a European journal of chemical biology, 15(8), 1154–1160. https://doi.org/https://doi.org/10.1002/cbic.201300754
- Chuang, C. H., Yeh, C. L., Yeh, S. L., Lin, E. S., Wang, L. Y., & Wang, Y. H. (2016). Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms. The Journal of Nutritional Biochemistry, 33, 45–53. https://doi.org/https://doi.org/10.1016/j.jnutbio.2016.03.011
- Corigliano, D. M., Syed, R., Messineo, S., Lupia, A., Patel, R., Reddy, C. V. R., Dubey, P. K., Colica, C., Amato, R., De Sarro, G., Alcaro, S., Indrasena, A., & Brunetti, A. (2018). Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators. PeerJ., 6, e5386. https://doi.org/https://doi.org/10.7717/peerj.5386
- Dwyer, J. T., Coates, P. M., & Smith, M. J. (2018). Dietary supplements: Regulatory challenges and research resources. Nutrients, 10(1), 41. https://doi.org/https://doi.org/10.3390/nu10010041
- Farhan, M., Ullah, M., Faisal, M., Farooqi, A., Sabitaliyevich, U., Biersack, B., & Ahmad, A. (2019). Differential methylation and acetylation as the epigenetic basis of resveratrol's anticancer activity. Medicines ( Medicines), 6(1), 24. https://doi.org/https://doi.org/10.3390/medicines6010024
- Floyd, Z. E., Wang, Z. Q., Kilroy, G., & Cefalu, W. T. (2008). Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism: Clinical and Experimental, 57(7 Suppl 1), S32–S38. https://doi.org/https://doi.org/10.1016/j.metabol.2008.04.006
- Guedes, I. A., S., de Magalhães, C., & Dardenne, L. E. (2014). Receptor-ligand molecular docking. Biophysical Reviews, 6(1), 75–87. https://doi.org/https://doi.org/10.1007/s12551-013-0130-2
- Hashemzaei, M., Delarami Far, A., Yari, A., Heravi, R. E., Tabrizian, K., Taghdisi, S. M., Sadegh, S. E., Tsarouhas, K., Kouretas, D., Tzanakakis, G., Nikitovic, D., Anisimov, N. Y., Spandidos, D. A., Tsatsakis, A. M., & Rezaee, R. (2017). Anticancer and apoptosis‑inducing effects of quercetinin vitro and in vivo. Oncology Reports, 38(2), 819–828. https://doi.org/https://doi.org/10.3892/or.2017.5766
- Hua, T. N. M., Namkung, J., Phan, A. N. H., Vo, V. T. A., Kim, M. K., Jeong, Y., & Choi, J. W. (2018). PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation. Journal of Receptor and Signal Transduction Research, 38(3), 191–197. https://doi.org/https://doi.org/10.1080/10799893.2018.1468781
- Igura, K., Ohta, T., Kuroda, Y., & Kaji, K. (2001). Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Letters, 171(1), 11–16. https://doi.org/https://doi.org/10.1016/S0304-3835(01)00443-8
- Imran, M., Salehi, B., Sharifi-Rad, J., Aslam Gondal, T., Saeed, F., Imran, A., Shahbaz, M., Tsouh Fokou, P. V., Umair Arshad, M., Khan, H., Guerreiro, S. G., Martins, N., & Estevinho, L. M. (2019). Kaempferol: A key emphasis to its anticancer potential. Molecules, 24(12), 2277. https://doi.org/https://doi.org/10.3390/molecules24122277
- Keshamouni, V. G., Arenberg, D. A., Reddy, R. C., Newstead, M. J., Anthwal, S., & Standiford, T. J. (2005). PPAR-gamma activation inhibits angiogenesis by blocking ELR + CXC chemokine production in non-small cell lung cancer. Neoplasia (New York, N.Y.).), 7(3), 294–301. https://doi.org/https://doi.org/10.1593/neo.04601
- Kim, M. J., Lee, Y. J., Yoon, Y. S., Kim, M., Choi, J. H., Kim, H. S., & Kang, J. L. (2018). Apoptotic cells trigger the ABCA1/STAT6 pathway leading to PPAR-γ expression and activation in macrophages. Journal of Leukocyte Biology, 103(5), 885–895. https://doi.org/https://doi.org/10.1002/JLB.2A0817-341RR
- Lalloyer, F., & Staels, B. (2010). Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(5), 894–899. https://doi.org/https://doi.org/10.1161/ATVBAHA.108.179689
- Lee, S. M., Moon, J., Cho, Y., Chung, J. H., & Shin, M. J. (2013). Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line. Nutrition Research (New York, N.Y.).), 33(2), 136–143. https://doi.org/https://doi.org/10.1016/j.nutres.2012.11.010
- Lipscombe, L. L., Gomes, T., Lévesque, L. E., Hux, J. E., Juurlink, D. N., & Alter, D. A. (2007). Thiazolidinediones, cardiovascular outcomes in older patients with diabetes. JAMA, 298(22), 2634–2643. https://doi.org/https://doi.org/10.1001/jama.298.22.2634
- Lokhande, K. B., Doiphode, S., Vyas, R., & Swamy, K. V. (2020). Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. Journal of BiomolecularStructure & Dynamics, 1–12. Advance online publication. https://doi.org/https://doi.org/10.1080/07391102.2020.1805019
- Mann, J. (2002). Natural products in cancer chemotherapy: Past, present and future. Nature Reviews. Cancer, 2(2), 143–148. https://doi.org/https://doi.org/10.1038/nrc723
- Mansure, J. J., Nassim, R., Chevalier, S., Szymanski, K., Rocha, J., Aldousari, S., & Kassouf, W. (2013). A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer. PLoS One., 8(2), e55997. https://doi.org/https://doi.org/10.1371/journal.pone.0055997
- Mazumder, M., Ponnan, P., Das, U., Gourinath, S., Khan, H. A., Yang, J., & Sakharkar, M. K. (2017). Investigations on binding pattern of kinase inhibitors with PPARγ: Molecular docking, molecular dynamic simulations, and free energy calculation studies. PPAR Research, 2017, 6397836. https://doi.org/https://doi.org/10.1155/2017/6397836
- Pathak, R. K., Gupta, A., Shukla, R., & Baunthiyal, M. (2018). Identification of new drug-like compounds from millets as Xanthine oxidoreductase inhibitors for treatment of Hyperuricemia: A molecular docking and simulation study. Computational Biology and Chemistry, 76, 32–41. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2018.05.015
- Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One, 5(8), e12029. https://doi.org/https://doi.org/10.1371/journal.pone.0012029
- Penumetcha, M., & Santanam, N. (2012). Nutraceuticals as ligands of PPARγ. PPAR Research, 2012, 858352. https://doi.org/https://doi.org/10.1155/2012/858352
- Plutzky, J. (2011). The PPAR-RXR transcriptional complex in the vasculature: Energy in the balance. Circulation Research, 108(8), 1002–1016. https://doi.org/https://doi.org/10.1161/CIRCRESAHA.110.226860
- Qin, L., Ren, Y., Chen, A.-M., Guo, F.-J., Xu, F., Gong, C., Cheng, P., Du, Y., & Liao, H. (2014). Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. Molecular Medicine Reports, 10(1), 276–282. https://doi.org/https://doi.org/10.3892/mmr.2014.2198
- Rizos, C. V., Elisaf, M. S., Mikhailidis, D. P., & Liberopoulos, E. N. (2009). How safe is the use of thiazolidinediones in clinical practice. Expert Opinion on Drug Safety, 8(1), 15–32. https://doi.org/https://doi.org/10.1517/14740330802597821
- Rosen, E. D., & Spiegelman, B. M. (2001). PPARgamma : A nuclear regulator of metabolism, differentiation, and cell growth. The Journal of Biological Chemistry, 276(41), 37731–37734. https://doi.org/https://doi.org/10.1074/jbc.R100034200
- Schrödinger Release. 2018. 2018-4: Maestro, Schrödinger, LLC, New York, NY.
- Silva, D. G., & Emery, F. D. S. (2018). Strategies towards expansion of chemical space of naturalproduct‑based compounds to enable drug discovery. Brazilian Journal of Pharmaceutical Science, 54, e01004. https://doi.org/https://doi.org/10.1590/s2175-97902018000001004
- Vallée, A., Lecarpentier, Y., & Vallée, J. N. (2019). Targeting the canonical WNT/β-catenin pathway in cancer treatment using non-steroidal anti-inflammatory drugs. Cells, 8(7), 726. https://doi.org/https://doi.org/10.3390/cells8070726
- Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/https://doi.org/10.1021/acs.chemrev.9b00055
- Welch, L. S., Dement, J. M., Cranford, K., Shorter, J., Quinn, P. S., Madtes, D. K., & Ringen, K. (2019). Early detection of lung cancer in a population at high risk due to occupation and smoking. Occupational and Environmental Medicine, 76(3), 137–142. https://doi.org/https://doi.org/10.1136/oemed-2018-105431
- Yeh, S. L., Yeh, C. L., Chan, S. T., & Chuang, C. H. (2011). Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR-γ expression in human A549 lung cancer cells. Planta Medica, 77(10), 992–998. https://doi.org/https://doi.org/10.1055/s-0030-1250735
- Yeon, M. J., Lee, M. H., Kim, D. H., Yang, J. Y., Woo, H. J., Kwon, H. J., Moon, C., Kim, S.-H., & Kim, J.-B. (2019). Anti-inflammatory effects of Kaempferol on Helicobacter pylori-induced inflammation. Bioscience, Biotechnology, and Biochemistry, 83(1), 166–173. https://doi.org/https://doi.org/10.1080/09168451.2018.1528140